Literature DB >> 12507781

CTLA4 is associated with susceptibility to multiple sclerosis.

Orhun H Kantarci1, David D Hebrink, Sara J Achenbach, Elizabeth J Atkinson, Alicja Waliszewska, Guy Buckle, Cynthia T McMurray, Mariza de Andrade, David A Hafler, Brian G Weinshenker.   

Abstract

We comprehensively screened CTLA4 for novel genetic variations in patients with MS. We studied genetic variations by association methods in a population-based sample of 122 sporadic patients with MS and 244 age-, gender- and ethnicity-matched controls, and by linkage and family-based association methods in 395 individuals from 59 American multiplex pedigrees with 141 affected individuals. Being homozygous for AT(8) (common) allele of the 3'(514) microsatellite (OR: 1.69; CI: 0.99-2.86) and for the common 5'(318)*C/E1(49)*A/3'(514*AT(8) haplotype (OR: 1.96; CI: 1.13-3.39) was associated with increased susceptibility to MS in Olmsted County. The genotype frequencies of other individual polymorphisms were not significantly different between cases and controls. A pooled analysis of association studies revealed an odds ratio of 1.28 (95% CI: 1.01-1.63; p=0.043) for 5'(-318)*C homozygotes and 1.28 (95% CI: 1.08-1.51; p=0.005) for the 3'(514)*AT(8) allele. We did not detect linkage with MS susceptibility in multiplex families. We did not find a strong association with age at onset, disease course or severity. CTLA-4 is associated with susceptibility to MS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12507781     DOI: 10.1016/s0165-5728(02)00395-8

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  19 in total

Review 1.  Immune checkpoints in central nervous system autoimmunity.

Authors:  Nicole Joller; Anneli Peters; Ana C Anderson; Vijay K Kuchroo
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 2.  Molecular mechanisms of T-cell receptor and costimulatory molecule ligation/blockade in autoimmune disease therapy.

Authors:  Joseph R Podojil; Stephen D Miller
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

3.  Analysis of thyroglobulin gene polymorphisms in patients with autoimmune thyroiditis.

Authors:  Mariela Caputo; Carina M Rivolta; Teresa Mories; Juan J Corrales; Purificación Galindo; Rogelio González-Sarmiento; Héctor M Targovnik; José M Miralles-García
Journal:  Endocrine       Date:  2010-03-18       Impact factor: 3.633

Review 4.  Targeting the B7 family of co-stimulatory molecules: successes and challenges.

Authors:  Joseph R Podojil; Stephen D Miller
Journal:  BioDrugs       Date:  2013-02       Impact factor: 5.807

Review 5.  [Multiple sclerosis: potential therapeutic options and update of ongoing studies].

Authors:  H Wiendl; H C Lehmann; R Hohlfeld; H-P Hartung; B C Kieseier
Journal:  Nervenarzt       Date:  2004-06       Impact factor: 1.214

6.  Astrocytes protect the CNS: antigen-specific T helper cell responses are inhibited by astrocyte-induced upregulation of CTLA-4 (CD152).

Authors:  Ulrike Gimsa; Anita ØRen; Pushpa Pandiyan; Daniela Teichmann; Ingo Bechmann; Robert Nitsch; Monika C Brunner-Weinzierl
Journal:  J Mol Med (Berl)       Date:  2004-03-09       Impact factor: 4.599

Review 7.  Genetic analysis of the exon 1 position 49 CD152 dimorphism in multiple sclerosis.

Authors:  Rodney Stuart; Amy E Lovett-Racke; Elliot M Frohman; Kathleen Hawker; Michael K Racke
Journal:  J Neuroimmunol       Date:  2007-10-24       Impact factor: 3.478

8.  Cytotoxic T lymphocyte associated antigen-4 gene polymorphisms confer susceptibility to primary biliary cirrhosis and autoimmune hepatitis in Chinese population.

Authors:  Lie-Ying Fan; Xiao-Qing Tu; Qu-Bo Cheng; Ye Zhu; Ralph Feltens; Thomas Pfeiffer; Ren-Qian Zhong
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

9.  Regulatory and pro-inflammatory phenotypes of myelin basic protein-autoreactive T cells in multiple sclerosis.

Authors:  Jian Hong; Haiyan Li; Meiyue Chen; Ying C Q Zang; Sheri M Skinner; James M Killian; Jingwu Z Zhang
Journal:  Int Immunol       Date:  2009-10-11       Impact factor: 4.823

10.  Cross-linking of CD80 on CD4+ T cells activates a calcium-dependent signaling pathway.

Authors:  Joseph R Podojil; Stephen D Miller
Journal:  J Immunol       Date:  2009-01-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.